Swiss pharmaceuticals group Novartis tapped industry veteran and banking high-flier Jonathan Symonds to succeed Raymund Breu as chief financial officer, in a move welcomed by the market. Symonds, who spent eight years as CFO of UK-based rival Astrazeneca, will join Novartis on Sept. 1 from Goldman Sachs, where he is managing director of investment banking.
Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.
The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.
Compelling solutions through strategic partnerships
Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.
